Tenet Healthcare (NYSE:THC) Director Nadja West Sells 2,178 Shares of Stock

by · The Cerbat Gem

Tenet Healthcare Corporation (NYSE:THC – Get Free Report) Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares in the company, valued at $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tenet Healthcare Stock Up 1.1%

THC stock traded up $2.12 during midday trading on Thursday, hitting $197.14. The company’s stock had a trading volume of 11,010 shares, compared to its average volume of 1,374,247. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.64. The company’s fifty day moving average price is $202.87 and its 200 day moving average price is $186.01. The stock has a market capitalization of $17.33 billion, a P/E ratio of 13.51, a PEG ratio of 0.86 and a beta of 1.44. Tenet Healthcare Corporation has a twelve month low of $109.82 and a twelve month high of $222.82.

Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 EPS for the quarter, beating the consensus estimate of $3.33 by $0.37. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The firm had revenue of $5.29 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same period in the prior year, the firm posted $2.93 earnings per share. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, equities research analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds have recently bought and sold shares of THC. HighTower Advisors LLC grew its position in shares of Tenet Healthcare by 34.3% during the 1st quarter. HighTower Advisors LLC now owns 8,742 shares of the company’s stock worth $1,176,000 after purchasing an additional 2,232 shares in the last quarter. Tocqueville Asset Management L.P. bought a new position in Tenet Healthcare during the 1st quarter worth $271,000. Raymond James Financial Inc. raised its holdings in Tenet Healthcare by 17.6% in the 1st quarter. Raymond James Financial Inc. now owns 456,331 shares of the company’s stock valued at $61,377,000 after acquiring an additional 68,150 shares in the last quarter. Brooklyn Investment Group grew its holdings in shares of Tenet Healthcare by 908.7% during the 1st quarter. Brooklyn Investment Group now owns 232 shares of the company’s stock worth $31,000 after purchasing an additional 209 shares in the last quarter. Finally, Andina Capital Management LLC acquired a new position in Tenet Healthcare in the first quarter valued at about $434,000. 95.44% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on THC. The Goldman Sachs Group started coverage on shares of Tenet Healthcare in a research note on Tuesday, October 14th. They issued a “buy” rating and a $224.00 price target for the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $247.00 target price on shares of Tenet Healthcare in a report on Thursday. Wells Fargo & Company boosted their price target on Tenet Healthcare from $238.00 to $252.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Raymond James Financial set a $245.00 price objective on Tenet Healthcare in a research report on Wednesday, October 29th. Finally, Bank of America boosted their target price on Tenet Healthcare from $205.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $231.81.

View Our Latest Stock Report on THC

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Further Reading